awards grant
- Anti-EGFR Drug Conjugates for the Treatment of Colorectal and Breast Cancer
- Mechanisms of Bcl-2 pro-survival protein regulation in normal physiology, tumourigenesis and drug responsiveness
- Regulation of Cell Polarity and Tumourigenesis by Tetraspanin 6
- Type I interferon regulators as prognostic markers and predictors of therapeutic response in triple negative breast cancer